JP2018535195A5 - - Google Patents

Download PDF

Info

Publication number
JP2018535195A5
JP2018535195A5 JP2018516719A JP2018516719A JP2018535195A5 JP 2018535195 A5 JP2018535195 A5 JP 2018535195A5 JP 2018516719 A JP2018516719 A JP 2018516719A JP 2018516719 A JP2018516719 A JP 2018516719A JP 2018535195 A5 JP2018535195 A5 JP 2018535195A5
Authority
JP
Japan
Prior art keywords
protein
conjugate
linker
conjugate according
reactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018516719A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018535195A (ja
JP6949832B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/073470 external-priority patent/WO2017055582A1/en
Publication of JP2018535195A publication Critical patent/JP2018535195A/ja
Publication of JP2018535195A5 publication Critical patent/JP2018535195A5/ja
Application granted granted Critical
Publication of JP6949832B2 publication Critical patent/JP6949832B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018516719A 2015-10-01 2016-09-30 タンパク質コンジュゲート Active JP6949832B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15187937.6 2015-10-01
EP15187937 2015-10-01
PCT/EP2016/073470 WO2017055582A1 (en) 2015-10-01 2016-09-30 Protein conjugates

Publications (3)

Publication Number Publication Date
JP2018535195A JP2018535195A (ja) 2018-11-29
JP2018535195A5 true JP2018535195A5 (cg-RX-API-DMAC7.html) 2019-11-07
JP6949832B2 JP6949832B2 (ja) 2021-10-13

Family

ID=54252136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018516719A Active JP6949832B2 (ja) 2015-10-01 2016-09-30 タンパク質コンジュゲート

Country Status (7)

Country Link
US (1) US11292825B2 (cg-RX-API-DMAC7.html)
EP (1) EP3355931B1 (cg-RX-API-DMAC7.html)
JP (1) JP6949832B2 (cg-RX-API-DMAC7.html)
CN (1) CN108136043B (cg-RX-API-DMAC7.html)
ES (1) ES2985999T3 (cg-RX-API-DMAC7.html)
MA (1) MA43348A (cg-RX-API-DMAC7.html)
WO (1) WO2017055582A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6983075B2 (ja) 2015-06-02 2021-12-17 ノヴォ ノルディスク アー／エス 極性の組換え延長部を有するインスリン
MA43348A (fr) 2015-10-01 2018-08-08 Novo Nordisk As Conjugués de protéines
EP3532497B1 (en) 2016-10-26 2024-07-24 The Board of Trustees of the Leland Stanford Junior University Modified immunoglobulin hinge regions to reduce hemagglutination
US10864279B2 (en) * 2016-12-16 2020-12-15 Industrial Technology Research Institute Linker-drug and antibody-drug conjugate (ADC) employing the same
MA49339A (fr) * 2017-04-05 2020-02-12 Novo Nordisk As Conjugués insuline-fc à extension oligomère
ES2997332T3 (en) * 2017-08-04 2025-02-17 Amgen Inc Method of conjugation of cys-mabs
US20240050583A1 (en) * 2020-12-08 2024-02-15 Harbour Biomed (Shanghai) Co., Ltd Protein-drug conjugate and site-specific conjugating method
CN113024669B (zh) * 2021-03-12 2022-06-14 北京华科泰生物技术股份有限公司 含氨基或羧基基团物质标记的rbp抗体、人rbp免疫层析检测试剂盒及其制备方法
CN115819611B (zh) * 2021-12-30 2024-05-28 君合盟生物制药(杭州)有限公司 生长激素融合蛋白及其制备方法和用途
CN115845032A (zh) * 2022-10-28 2023-03-28 深圳科兴药业有限公司 生长激素fc融合蛋白注射液及其用途
WO2025184552A2 (en) * 2024-03-01 2025-09-04 The Scripps Research Institute Dual gip/glp-1 peptide conjugates and methods of use

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE286509C (cg-RX-API-DMAC7.html)
DE257197C (cg-RX-API-DMAC7.html)
US3914252A (en) 1971-03-15 1975-10-21 Continental Oil Co Preparation of N-iodocompounds
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
EP0851925B1 (en) 1995-09-21 2005-08-03 Genentech, Inc. Human growth hormone variants
WO1998022577A1 (en) 1996-11-15 1998-05-28 Maria Grazia Masucci Fusion proteins having increased half-lives
CA2296770A1 (en) 1997-07-14 1999-01-28 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
EP1200124B1 (en) 1999-07-13 2008-09-10 Bolder Biotechnology, Inc. Erythropoietin-immunoglobulin fusion proteins
US20050287153A1 (en) 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
EP1240337B1 (en) 1999-12-24 2006-08-23 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
WO2002055532A2 (en) 2001-01-11 2002-07-18 Maxygen Aps Variant growth hormone molecules conjugated with macromolecular compounds
US20060183197A1 (en) 2001-01-11 2006-08-17 Andersen Kim V Variant growth hormone molecules conjugated with macromolecules compounds
US20020169125A1 (en) 2001-03-21 2002-11-14 Cell Therapeutics, Inc. Recombinant production of polyanionic polymers and uses thereof
WO2003042245A2 (en) 2001-11-12 2003-05-22 University Of Wales College Of Medicine Growth hormone variations in humans and their uses
GB2384001B (en) 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
EP2298805A3 (en) 2002-09-27 2011-04-13 Xencor, Inc. Optimized Fc variants and methods for their generation
US20040180054A1 (en) 2003-03-13 2004-09-16 Hanmi Pharm. Co., Ltd. Physiologically active polypeptide conjugate having prolonged in vivo half-life
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
EP1682584B1 (en) 2003-11-13 2013-04-17 Hanmi Science Co., Ltd. A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
CA2552043A1 (en) 2004-01-21 2005-08-04 Novo Nordisk A/S Transglutaminase mediated conjugation of peptides
KR100594607B1 (ko) 2004-11-03 2006-06-30 재단법인서울대학교산학협력재단 신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2006081249A2 (en) 2005-01-25 2006-08-03 Cell Therapeutics, Inc. Conjugates of biologically active proteins having a modified in vivo half-life
WO2006079641A2 (en) * 2005-01-27 2006-08-03 Novo Nordisk A/S Insulin derivatives conjugated with structurally well defined branched polymers
CN101123992A (zh) * 2005-02-16 2008-02-13 诺和诺德公司 缀合有结构完全确定的支化聚合物的促胰岛素剂的衍生物
KR100754667B1 (ko) 2005-04-08 2007-09-03 한미약품 주식회사 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
EP1874816A4 (en) 2005-04-26 2010-08-25 Medimmune Inc MODULATION OF THE ANTIBODY EFFECTOR FUNCTION BY "HINGE" DOMENGINE ENGINEERING
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
EP1968641B1 (en) 2005-12-12 2014-06-11 Innova Biosciences Limited Production of conjugates
US8334257B2 (en) 2005-12-20 2012-12-18 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
AU2007223888A1 (en) 2006-03-06 2007-09-13 Amunix, Inc. Genetic packages and uses thereof
WO2008019368A2 (en) 2006-08-07 2008-02-14 Teva Biopharmaceuticals Usa, Inc. Albumin-insulin fusion proteins
JP5323710B2 (ja) 2006-10-26 2013-10-23 ヤンセン バイオテツク，インコーポレーテツド ヒトに適合するモノクローナル抗体に使用するための方法
WO2008049711A1 (en) 2006-10-27 2008-05-02 Novo Nordisk A/S Peptide extended insulins
WO2008147456A2 (en) 2006-11-20 2008-12-04 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
WO2008092117A2 (en) 2007-01-25 2008-07-31 Xencor, Inc. Immunoglobulins with modifications in the fcr binding region
KR20080095141A (ko) 2007-04-23 2008-10-28 포항공과대학교 산학협력단 인간 알부민 링커를 통하여 면역글로불린의 Ｆｃ에 결합된생리학적 활성 폴리펩티드의 융합 폴리펩티드, 및 이의제조방법
CA2687377C (en) 2007-05-30 2013-05-14 Genexine Co., Ltd. Immunoglobulin fusion proteins
EP4119579A1 (en) 2007-05-31 2023-01-18 Genmab A/S Stable igg4 antibodies
WO2009015345A1 (en) 2007-07-25 2009-01-29 Amgen Inc. Pharmaceutical compositions comprising fc fusion proteins
EP2185701A4 (en) 2007-08-15 2011-03-02 Amunix Operating Inc COMPOSITIONS AND METHODS FOR ENHANCING THE PRODUCTION OF RECOMBINANT POLYPEPTIDES
US8586532B2 (en) 2007-08-24 2013-11-19 Novo Nordisk Healthcare A/G Method for selectively modifying a protein via transglutaminase catalyzed reaction
WO2009053368A1 (en) 2007-10-22 2009-04-30 Merck Serono S.A. Single ifn-beta fused to a mutated igg fc fragment
JP6146949B2 (ja) 2008-06-20 2017-06-21 ノバルティス アーゲー 凝集が低減された免疫グロブリン
US20110119848A1 (en) 2008-07-02 2011-05-26 Koninklijke Philips Electronics N.V. V-spring configuration and end attachment assemblies therefor for use in a personal care appliance
US9636420B2 (en) * 2008-07-23 2017-05-02 Hanmi Science Co., Ltd. Polypeptide complex comprising non-peptidyl polymer having three functional ends
EP2356142B1 (en) 2008-11-10 2016-08-10 Novo Nordisk A/S E. coli bl21 strain lacking a functional group ii capsular gene cluster.
DK3178835T3 (da) 2009-02-03 2019-06-24 Amunix Pharmaceuticals Inc Forlængede rekombinante polypeptider og sammensætninger omfattende samme
GB0914110D0 (en) 2009-08-12 2009-09-16 Medical Res Council Peptide libraries
WO2011028952A1 (en) 2009-09-02 2011-03-10 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
CN104147611A (zh) 2009-09-30 2014-11-19 葛兰素集团有限公司 具有延长的半衰期的药物融合体和缀合物
BR112012010252A2 (pt) 2009-10-29 2016-12-06 Janssen Biotech Inc variantes de glicosilação de anticorpo
US8637637B2 (en) 2010-01-12 2014-01-28 Bill Nai-Chau Sun Fc fusion proteins of human growth hormone
RS59459B1 (sr) 2010-01-22 2019-11-29 Novo Nordisk Healthcare Ag Hormoni rasta sa produženom in-vivo efikasnošću
JP5980689B2 (ja) 2010-01-22 2016-08-31 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
AR081066A1 (es) 2010-04-02 2012-06-06 Hanmi Holdings Co Ltd Conjugado de insulina donde se usa un fragmento de inmunoglobulina
MX357674B (es) 2010-05-21 2018-07-18 Xl Protein Gmbh Polipeptidos biosinteticos de espira aleatoria de prolina/alanina y sus usos.
KR101337797B1 (ko) 2010-07-14 2013-12-06 한미사이언스 주식회사 지속형 인간 성장 호르몬 결합체 액상 제제
WO2012010516A1 (en) 2010-07-22 2012-01-26 Novo Nordisk Health Care Ag Growth hormone conjugates
US9783571B2 (en) * 2011-04-05 2017-10-10 Warham Lance Martin Isolation of cysteine containing peptides
UA117901C2 (uk) 2011-07-06 2018-10-25 Ґенмаб Б.В. Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування
MX366864B (es) * 2012-02-27 2019-07-26 Amunix Operating Inc Composiciones de conjugados de xten y métodos para realizarlas.
CA2873112A1 (en) 2012-05-11 2013-11-14 Alexander Krantz Site-specific labeling and targeted delivery of proteins for the treatment of cancer
KR101993393B1 (ko) 2012-11-06 2019-10-01 한미약품 주식회사 옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
EP3004156A1 (en) 2013-06-07 2016-04-13 Novo Nordisk A/S Method for making mature insulin polypeptides
JP6822839B2 (ja) 2013-09-13 2021-01-27 ザ・スクリップス・リサーチ・インスティテュート 修飾された治療剤、及びその組成物
EP3663763B1 (en) 2013-11-26 2022-02-16 The Brigham and Women's Hospital, Inc. Compositions and methods for modulating an immune response
KR20160088429A (ko) 2013-11-26 2016-07-25 노파르티스 아게 케톤-변형된 폴리펩티드에 대한 옥심 접합을 위한 방법
TW201619188A (zh) 2014-03-05 2016-06-01 優稀美生物醫藥公司 多聚體Ｆｃ蛋白質
WO2016042093A1 (en) 2014-09-17 2016-03-24 Novo Nordisk A/S Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)
EP3260139A4 (en) 2015-02-17 2018-09-05 Hanmi Pharm. Co., Ltd. Long-acting insulin or insulin analogue complex
AR105616A1 (es) 2015-05-07 2017-10-25 Lilly Co Eli Proteínas de fusión
JP6983075B2 (ja) 2015-06-02 2021-12-17 ノヴォ ノルディスク アー／エス 極性の組換え延長部を有するインスリン
RU2698727C9 (ru) 2015-08-14 2022-03-30 Рс Биотекнолоджиз, Инк. Ковалентные линкеры в конъюгатах антитело-лекарственное средство, способы их получения и применение
MA43348A (fr) 2015-10-01 2018-08-08 Novo Nordisk As Conjugués de protéines
MA49339A (fr) 2017-04-05 2020-02-12 Novo Nordisk As Conjugués insuline-fc à extension oligomère
CN112839681A (zh) 2018-10-10 2021-05-25 诺和诺德股份有限公司 寡聚体延伸的胰岛素-Fc缀合物及其医学用途

Similar Documents

Publication Publication Date Title
JP2018535195A5 (cg-RX-API-DMAC7.html)
CN111201228B (zh) 作为Toll样受体7(TLR7)激动剂的6-氨基-7,9-二氢-8H-嘌呤-8-酮衍生物
JP2023113786A (ja) トル様受容体７（ｔｌｒ７）アゴニストとしての６－アミノ－７，９－ジヒドロ－８ｈ－プリン－８－オン誘導体
JP7159295B2 (ja) 免疫刺激因子トル様受容体７（ｔｌｒ７）アゴニストとしての、６－アミノ－７，９－ジヒドロ－８ｈ－プリン－８－オン誘導体
JP7228571B2 (ja) 免疫刺激因子トル様受容体７（ｔｌｒ７）アゴニストとしての６－アミノ―７，９－ジヒドロ－８ｈ－プリン－８－オン誘導体
JP2017536098A5 (cg-RX-API-DMAC7.html)
JP2020128417A5 (cg-RX-API-DMAC7.html)
JP2011505146A5 (cg-RX-API-DMAC7.html)
FI3268047T3 (fi) Uusia amatoksiini-vasta-ainekonjugaatteja
NO20060825L (no) Imaging Agents
US10597438B2 (en) PD-L1 binding fibronectin type III domains
US9175053B2 (en) Chemical preparation of ubiquitin thioesters and modifications thereof
US20210145976A1 (en) Cd71 binding fibronectin type iii domains
Kondasinghe et al. Direct palladium-mediated on-resin disulfide formation from Allocam protected peptides
JP6595600B2 (ja) 糖タンパク質連鎖による部位特異的な複合体形成およびその方法
JP2004507557A (ja) 求核物質に対して安定なチオエステル生成化合物、製造および使用の方法
JP5566905B2 (ja) 生体分子の選択的放射性標識
JPWO2022154127A5 (cg-RX-API-DMAC7.html)
CN118496347B (zh) 一种用于抗体寡核苷酸偶联的方法
CN104623687B (zh) 利用美登醇制备的抗体药物偶联物及其制备方法和应用
CN115335411A (zh) 一种TGFβR2胞外区截短分子、其与抗EGFR抗体的融合蛋白及其抗肿瘤用途
JP2004508383A (ja) 拡張天然型化学的ライゲーション
US10280194B2 (en) Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby
TWI519516B (zh) A compound having a bifunctional group and a method for producing the same
JP2013533254A (ja) ペプチド合成で使用するための化合物